national healthcare corporation - NHC
NHC
Close Chg Chg %
242.30 -6.77 -2.79%
Closed Market
235.53
-6.77 (2.79%)
Volume: 192.91K
Last Updated:
Oct 23, 2026, 3:59 PM EDT
Company Overview: national healthcare corporation - NHC
NHC Key Data
| Open $242.24 | Day Range 235.49 - 244.94 |
| 52 Week Range 118.14 - 248.87 | Market Cap $3.69B |
| Shares Outstanding 15.66M | Public Float 12.72M |
| Beta 0.61 | Rev. Per Employee N/A |
| P/E Ratio 26.48 | EPS $9.03 |
| Yield 107.79% | Dividend $0.67 |
| EX-DIVIDEND DATE Sep 30, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 109.06K |
NHC Performance
| 1 Week | -2.80% | ||
| 1 Month | 3.80% | ||
| 3 Months | 4.57% | ||
| 1 Year | 92.30% | ||
| 5 Years | 237.45% |
NHC Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
1
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
An error occurred while fetching the data.
SEC Filings for National Healthcare Corporation - NHC
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for National Healthcare Corporation - NHC
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Brian F. Kidd SVP, CFO | 23,183 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $225.7 per share | 5,232,403.10 |
| Sep 15, 2026 | Josh A. McCreary Senior VP & General Counsel | 12,127 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $222.73 per share | 2,701,046.71 |
| Sep 15, 2026 | Josh A. McCreary Senior VP & General Counsel | 11,338 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $223.78 per share | 2,537,217.64 |
| Sep 15, 2026 | Josh A. McCreary Senior VP & General Counsel | 10,047 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $225.09 per share | 2,261,479.23 |
| Sep 15, 2026 | Josh A. McCreary Senior VP & General Counsel | 9,979 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $225.59 per share | 2,251,162.61 |
| Jun 19, 2026 | Emil E. Hassan Director | 71,532 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $199.98 per share | 14,304,969.36 |
| May 7, 2026 | Richard A. LaRoche Director | 213,260 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $71.64 per share | 15,277,946.40 |
| May 7, 2026 | Richard A. LaRoche Director | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Mar 11, 2026 | James Paul Abernathy Director | 43,302 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $55.75 per share | 2,414,086.50 |
| Mar 11, 2026 | James Paul Abernathy Director | 4,360 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |